维普期刊资源整合服务平台（V6.5）

754篇 您的检索式：作者名="Libby M"

选中清除导出查看参考文献查看引证文献引用追踪共38页首页上一页第1页下一页末页 /38 跳转

	题名	作者	年代	出处	被引量
1	Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: Rationale and Design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS)显示文摘	Paul M Ridker Tom Thuren Andrew Zalewski Peter Libby	2011	American Heart Journal2011，，4：	2
2	Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial显示文摘	Paul M Ridker Aruna Pradhan Jean G MacFadyen Peter Libby Robert J Glynn	2012	2012 (9841)2012，，9841：	2
3	Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial显示文摘	Paul M Ridker Aruna Pradhan Jean G MacFadyen Peter Libby Robert J Glynn	2012	The Lancet2012，，9841：	2
4	From vulnerable plaque to vulnerable patient-A call for new definitions and risk assessment strategies:Part1显示文摘	NAGHAVI M LIBBY P FALK E	2003	Circulation2003，108，：	1
5	From vulnerable plaque to vulnera- ble patient :a call for new definitions and risk assessment strategies: Part I 显示文摘	Naghavi M Libby P Falk E	2003	Circulation2003，108，14：	1
6	From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies显示文摘	NAGHAVI M LIBBY P FALK E	2003	Cireulation2003，108，：	1
7	From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies:part II 显示文摘	Naghavi M Libby P Falk E	2003	Circulation2003，108，15：	1
8	From vulnerable plaque to vulnerable patient:a call for new definitions and risk assessment strategies显示文摘	Naghavi M Libby P Falk E	2003	Circulation2003，108，：	1
9	Inflammation and atherosclerosis显示文摘	LIBBY P RIDKER P M MASERI A	2002	Circulation2002，105，：	1
10	In- flammation and atherosclerosis显示文摘	Libby P Ridker P M Maseri A	2001	Cir- culation2001，105，9：	1
11	From vulnerable plaque to vulnera- ble patient:a call for new definitions and risk assessment strategies: Part I1 显示文摘	Naghavi M Libby P Falk E	2003	Circulation2003，108，15：	1
12	Inflammation and ather- osclerosis 显示文摘	Libby P Ridker P M Masefi A	2002	Circulation2002，105，9：	1
13	From vulnerable plaque to vulnerable patient:a call for new definitions and risk assessment strategies:part-I显示文摘	Naghavi M Libby P Falk E		0，，14：	1
14	From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies:Part Ⅰ 显示文摘	Naghavi M Libby P Falk E	2003	Circulation2003，108，14：	1
15	Cell dysfunction in atherosclerosis and the inchemic manifestations of coronary artery disease 显示文摘	Kinlay S Creager M Libby P Ganz P	1997	Am J Cardiol1997，79，5：	1
16	From vulnerable plaque to vulnerable patient:a call for new definitions and risk assessment strategies显示文摘	Naghavi M Libby P Falk E	2003	Circulation2003，108，：	1
17	Survival of patients with stage Ⅰ lung cancer detected on CT screening显示文摘	HENSCHKE C I YANKELEVITZ D F LIBBY D M	2006	N Engl J Med2006，355，17：	1
18	huqammation in there,- sclerosis 显示文摘	LIBBY P RIDKER P M MASERI A	2002	Circulation2002，105，9：	1
19	Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases Working Group on cardiovascular complications of type 1 diabetes mellitus显示文摘	Peter Libby David M Nathan Kristin Abraham	2005	Cir- culation2005，111，：	1
20	From vulnerable plaque to vulnerable patient:a call for new definitions and risk assessment strategies:Part Ⅱ显示文摘	Naghavi M Libby P Falk E	2003	Circulation2003，108，15：	1

返回顶部每页显示：

共38页首页上一页第1页下一页末页 /38 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示